Výsledky vyhledávání - "BRYKALSKI, D."

Diagnostic value of 169Yb-cis-dichlorodimethionine platinum scintigraphy in patients with malignant lymphomas

Autor: Liniecki J, Kukulski K, Brykalski D, Zadrozna O, Kapuściński J

Publikováno v: Nuclear medicine communications. 16(9)

Ytterbium-169 ( 169 Yb) cis-dichlorodimethionine platinum ( 169 Yb-PtCl 2 Meth 2 ) is a new agent of low toxicity with an affinity for neoplastic tumours. The aim of this study was to assess the diagnostic value of 169 Yb-PtCl 2 Meth 2 scintigraphy i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ccb77675f5b461d17f89ab0604da6a0
https://pubmed.ncbi.nlm.nih.gov/7478407

Zobrazit plný text záznamu

Akademický článek

Diagnostic value of ¹⁶⁹Yb-cis-dichlorodimethionine platinum scintigraphy in patients with malignant lymphomas.

Autor: KUKULSKI, K., LINIECKI, J., BRYKALSKI, D., ZADROŻNA, O., KAPUŚCINSKI, J.

Publikováno v: Nuclear Medicine Communications; Sep1995, Vol. 16 Issue 9, p747-755, 9p

Zobrazit plný text záznamu

Akademický článek

Experimental Investigations on Penetration of Radioactive Chromium (Cr⁵¹) through the Skin.

Autor: Czernielewski, A., Brykalski, D., Depczyk, D.

Publikováno v: Dermatologica; 1965, Vol. 131 Issue 5, p384-396, 13p

Zobrazit plný text záznamu

51Cr-Bleomycin, a New Oncophilic Radiopharmaceutical II. Scintigraphic Diagnosis of Malignant Neoplasms

Autor: Brykalski D, M. Rembelska, T. Pertynski, S. Fajndt, J. Liniecki, Durski K

Publikováno v: Nuklearmedizin - NuclearMedicine. 21:68-71

51Cr-bleomycin was used for the scintigraphic detection of tumours and the assessment of the spread of the disease in 20 patients with various malignances: 7 with Hodgkins Lymphoma, 5 with other malignant lymphomas, 4 cases of cervix carcinoma and 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::691736979abffb4cf7a155e488300183
https://doi.org/10.1055/s-0037-1620555

Zobrazit plný text záznamu